Targeting bile‐acid signalling for metabolic diseases
Open accessThe DOI matches its Crossref record; 165 of the 169 references it cites were found in a registry or an index.
Abstract
Bile acids are increasingly being appreciated as complex metabolic integrators and signalling factors and not just as lipid solubilizers and simple regulators of bile-acid homeostasis. It is therefore not surprising that a number of bile-acid-activated signalling pathways have become attractive therapeutic targets for metabolic disorders. Here, we review how the signalling functions of bile acids can be exploited in the development of drugs for obesity, type 2 diabetes, hypertriglyceridaemia and atherosclerosis, as well as other associated chronic diseases such as non-alcoholic steatohepatitis.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Through FXR activation, OCA modulates bile acid synthesis, absorption, transport, secretion, and metabolism, with a net effect of choleresis.(157,158)”
From Primary Biliary Cholangitis: 2018 Practice Guidance from the American Association for the Study of Liver Diseases (2019) · cites this paper as [157]
In the citing paper
“In animal models, FXR activation has demonstrated antifibrotic and anti-inflammatory properties as well.(157)”
From Primary Biliary Cholangitis: 2018 Practice Guidance from the American Association for the Study of Liver Diseases (2019) · cites this paper as [157]
In the citing paper
“After conjugation with either taurine or glycine, primary bile acids are released into the intestine to assist with lipid digestion and are recycled back into the liver (Thomas et al., 2008).”
From The Microbiota-Gut-Brain Axis (2019) · cites this paper as Thomas et al., 2008
In the citing paper
“By activating nuclear farnesoid X receptor (FXR) and plasma membrane TGR5 receptor, bile acids were shown to regulate systemic lipid, cholesterol, and glucose metabolism, as well as energy and immune homeostasis (Calmus and Poupon, 2014;de Aguiar Vallim et al., 2013;Thomas et al., 2008).”
From The Microbiota-Gut-Brain Axis (2019) · cites this paper as Thomas et al., 2008
In the citing paper
“In addition, FXR regulates other pathways with direct antiinflammatory and antifibrotic effects. 13-15”
From A Placebo-Controlled Trial of Obeticholic Acid in Primary Biliary Cholangitis (2016) · cites this paper as [13]
4 more claims about this paper
Create a free account to see every claim other papers make about this one.
Citations
Cites
An obesity-associated gut microbiome with increased capacity for energy harvest
Turnbaugh, P. J., Ley, R. E., Mahowald, M. A., Magrini, V., Mardis, E. R., & Gordon, J. I. (2006) · Nature · doi:10.1038/nature05414 · Cited by 12,444
International Union of Pharmacology: Approaches to the Nomenclature of Voltage-Gated Ion Channels
Catterall, W. A., Chandy, K. G., Clapham, D. E., Gutman, G. A., Hofmann, F., Harmar, A. J., Abernethy, D. R., & Spedding, M. (2003) · Pharmacological Reviews · doi:10.1124/pr.55.4.5 · Cited by 7,126
SREBPs: activators of the complete program of cholesterol and fatty acid synthesis in the liver
Horton, J. D., Goldstein, J. L., & Brown, M. S. (2002) · Journal of Clinical Investigation · doi:10.1172/jci15593 · Cited by 4,794
SREBPs: activators of the complete program of cholesterol and fatty acid synthesis in the liver
Horton, J. D., Goldstein, J. L., & Brown, M. S. (2002) · Journal of Clinical Investigation · doi:10.1172/jci0215593 · Cited by 4,092
The Physiology of Glucagon-like Peptide 1
Holst, J. J. (2007) · Physiological Reviews · doi:10.1152/physrev.00034.2006 · Cited by 3,371
Identification of a nuclear receptor for bile acids
Makishima, M., Okamoto, A. Y., Repa, J. J., Tu, H., Learned, R. M., Luk, A., Hull, M. V., Lustig, K. D., Mangelsdorf, D. J., & Shan, B. (1999) · Science · doi:10.1126/science.284.5418.1362 · Cited by 2,714
Özcan, U., Yilmaz, E., Özcan, L., Furuhashi, M., Vaillancourt, E., Smith, R. O., Görgün, C. Z., & Hotamisligil, G. S. (2006) · Science · doi:10.1126/science.1128294 · Cited by 2,413
Bile Acids: Natural Ligands for an Orphan Nuclear Receptor
Parks, D. J., Blanchard, S. G., Bledsoe, R. K., Chandra, G., Consler, T. G., Kliewer, S. A., Stimmel, J. B., Willson, T. M., Zavacki, A. M., Moore, D. D., et al. (1999) · Science · doi:10.1126/science.284.5418.1365 · Cited by 2,274
Bile acids induce energy expenditure by promoting intracellular thyroid hormone activation
Watanabe, M., Houten, S. M., Mataki, C., Christoffolete, M. A., Kim, B. W., Sato, H., Messaddeq, N., Harney, J. W., Ezaki, O., Kodama, T., et al. (2006) · Nature · doi:10.1038/nature04330 · Cited by 2,220
Self-citationThe Enzymes, Regulation, and Genetics of Bile Acid Synthesis
Russell, D. W. (2003) · Annual Review of Biochemistry · doi:10.1146/annurev.biochem.72.121801.161712 · Cited by 2,069
A regulatory cascade of the nuclear receptors FXR, SHP-1, and LRH-1 represses bile acid biosynthesis
Goodwin, B., Jones, S. A., Price, R. R., Watson, M. A., McKee, D. D., Moore, L. B., Galardi, C., Wilson, J. G., Lewis, M. C., Roth, M. E., et al. (2000) · Molecular Cell · doi:10.1016/s1097-2765(00)00051-4 · Cited by 1,940
Fibroblast growth factor 15 functions as an enterohepatic signal to regulate bile acid homeostasis
Inagaki, T., Choi, M., Moschetta, A., Peng, L., Cummins, C. L., McDonald, J. G., Luo, G., Jones, S. A., Goodwin, B., Richardson, J. A., et al. (2005) · Cell Metabolism · doi:10.1016/j.cmet.2005.09.001 · Cited by 1,865
Targeted Disruption of the Nuclear Receptor FXR/BAR Impairs Bile Acid and Lipid Homeostasis
Sinal, C. J., Tohkin, M., Miyata, M., Ward, J. M., Lambert, G., & Gonzalez, F. J. (2000) · Cell · doi:10.1016/s0092-8674(00)00062-3 · Cited by 1,819
Repa, J. J., Liang, G., Ou, J., Bashmakov, Y., Lobaccaro, J.-M. A., Shimomura, I., Shan, B., Brown, M. S., Goldstein, J. L., & Mangelsdorf, D. J. (2000) · Genes & Development · doi:10.1101/gad.844900 · Cited by 1,692
Endogenous Bile Acids Are Ligands for the Nuclear Receptor FXR/BAR
Wang, H., Chen, J., Hollister, K., Sowers, L. C., & Forman, B. M. (1999) · Molecular Cell · doi:10.1016/s1097-2765(00)80348-2 · Cited by 1,636
A G Protein-coupled Receptor Responsive to Bile Acids
Kawamata, Y., Fujii, R., Hosoya, M., Harada, M., Yoshida, H., Miwa, M., Fukusumi, S., Habata, Y., Itoh, T., Shintani, Y., et al. (2003) · Journal of Biological Chemistry · doi:10.1074/jbc.m209706200 · Cited by 1,628
Role of LXRs in control of lipogenesis
Schultz, J. R., Tu, H., Luk, A., Repa, J. J., Medina, J. C., Li, L., Schwendner, S., Wang, S., Thoolen, M., Mangelsdorf, D. J., et al. (2000) · Genes & Development · doi:10.1101/gad.850400 · Cited by 1,499
Molecular Basis for Feedback Regulation of Bile Acid Synthesis by Nuclear Receptors
Lu, T. T., Makishima, M., Repa, J. J., Schoonjans, K., Kerr, T. A., Auwerx, J., & Mangelsdorf, D. J. (2000) · Molecular Cell · doi:10.1016/s1097-2765(00)00050-2 · Cited by 1,487
Self-citationBile acids lower triglyceride levels via a pathway involving FXR, SHP, and SREBP-1c
渡辺, 光., Houten, S. M., Wang, L., Moschetta, A., Mangelsdorf, D. J., Heyman, R. A., Moore, D. D., & Auwerx, J. H. (2004) · Journal of Clinical Investigation · doi:10.1172/jci200421025 · Cited by 1,397
Self-citationThe nuclear receptor PXR is a lithocholic acid sensor that protects against liver toxicity
Staudinger, J. L., Goodwin, B., Jones, S. A., Hawkins-Brown, D., MacKenzie, K. I., LaTour, A., Liu, Y., Klaassen, C. D., Brown, K. K., Reinhard, J., et al. (2001) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.051551698 · Cited by 1,379
Ji, T. H., Grossmann, M., & Ji, I. (1998) · Journal of Biological Chemistry · doi:10.1074/jbc.273.28.17299 · Cited by 1,277
Identification of a nuclear receptor that is activated by farnesol metabolites
Forman, B. M., Goode, E., Chen, J., Oro, A. E., Bradley, D. J., Perlmann, T., Noonan, D. J., Burka, L. T., McMorris, T., Lamph, W. W., et al. (1995) · Cell · doi:10.1016/0092-8674(95)90530-8 · Cited by 1,210
Vitamin D Receptor As an Intestinal Bile Acid Sensor
Makishima, M., Lu, T. T., Xie, W., Whitfield, G. K., Domoto, H., Evans, R. M., Haussler, M. R., & Mangelsdorf, D. J. (2002) · Science · doi:10.1126/science.1070477 · Cited by 1,176
Regulation of antibacterial defense in the small intestine by the nuclear bile acid receptor
Inagaki, T., Moschetta, A., Lee, Y.-K., Peng, L., Zhao, G., Downes, M., Yu, R. T., Shelton, J. M., Richardson, J. A., Repa, J. J., et al. (2006) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0509592103 · Cited by 1,164 · cited 1×
“Furthermore, as bile acids are bacteriostatic in the intestine, FXR-α activation has been shown to be enteroprotective, resulting in the prevention of bacterial overgrowth and subsequent epithelial deterioration and bacterial translocatio”
BackgroundSymbiotic gut microbes modulate human metabolic phenotypes
Li, M., Wang, B., Zhang, M., Rantalainen, M., Wang, S., Zhou, H., Zhang, Y., Shen, J., Pang, X., Zhang, M., et al. (2008) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0712038105 · Cited by 1,144
Bile salt transporters: molecular characterization, function, and regulation
Trauner, M., & Boyer, J. L. (2003) · Physiological Reviews · doi:10.1152/physrev.00027.2002 · Cited by 999
Identification of membrane-type receptor for bile acids (M-BAR)
Maruyama, T., Miyamoto, Y., Nakamura, T., Tamai, Y., Okada, H., Sugiyama, E., Nakamura, T., Itadani, H., & Tanaka, K. (2002) · Biochemical and Biophysical Research Communications · doi:10.1016/s0006-291x(02)02550-0 · Cited by 993
Activation of the nuclear receptor FXR improves hyperglycemia and hyperlipidemia in diabetic mice
Zhang, Y., Lee, F. Y., Barrera, G., Lee, H., Vales, C., Gonzalez, F. J., Willson, T. M., & Edwards, P. A. (2006) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0506982103 · Cited by 953
Farnesoid X receptor is essential for normal glucose homeostasis
Ma, K. (2006) · Journal of Clinical Investigation · doi:10.1172/jci25604 · Cited by 882
Shimomura, I., Bashmakov, Y., Ikemoto, S., Horton, J. D., Brown, M. S., & Goldstein, J. L. (1999) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.96.24.13656 · Cited by 793
Katsuma, S., Hirasawa, A., & Tsujimoto, G. (2005) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2005.01.139 · Cited by 789
An essential role for nuclear receptors SXR/PXR in detoxification of cholestatic bile acids
Xie, W., Radominska-Pandya, A., Shi, Y., Simon, C. M., Nelson, M. C., Ong, E. S., Waxman, D. J., & Evans, R. M. (2001) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.051014398 · Cited by 757
H1-Receptor Antagonists: Comparative Tolerability and Safety
Estelle, F., & Simons, R. (1994) · Drug Safety · doi:10.2165/00002018-199410050-00002 · Cited by 751
Foretz, M., Guichard, C., Ferré, P., & Foufelle, F. (1999) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.96.22.12737 · Cited by 747
Pellicciari, R., Fiorucci, S., Camaioni, E., Clerici, C., Costantino, G., Maloney, P. R., Morelli, A., Parks, D. J., & Willson, T. M. (2002) · Journal of Medicinal Chemistry · doi:10.1021/jm025529g · Cited by 743
Self-citationHolt, J. A., Luo, G., Billin, A. N., Bisi, J., McNeill, Y. Y., Kozarsky, K. F., Donahee, M., Wang, D. Y., Mansfield, T. A., Kliewer, S. A., et al. (2003) · Genes & Development · doi:10.1101/gad.1083503 · Cited by 696
Nuclear Receptor-Dependent Bile Acid Signaling Is Required for Normal Liver Regeneration
Huang, W., Ma, K., Zhang, J., Qatanani, M., Cuvillier, J., Liu, J., Dong, B., Huang, X., & Moore, D. D. (2006) · Science · doi:10.1126/science.1121435 · Cited by 645
Muscarinic acetylcholine receptors: mutant mice provide new insights for drug development
Wess, J., Eglen, R. M., & Gautam, D. (2007) · Nature Reviews Drug Discovery · doi:10.1038/nrd2379 · Cited by 637
Nuclear Receptors and the Control of Metabolism
Francis, G. A., Fayard, E., Picard, F., & Auwerx, J. (2003) · Annual Review of Physiology · doi:10.1146/annurev.physiol.65.092101.142528 · Cited by 636
Self-citationFormyl-peptide receptors revisited
LE, Y., MURPHY, P., & WANG, J. (2002) · Trends in Immunology · doi:10.1016/s1471-4906(02)02316-5 · Cited by 597
International Union of Pharmacology. XLVI. G Protein-Coupled Receptor List
Foord, S. M., Bonner, T. I., Neubig, R. R., Rosser, E. M., Pin, J.-P., Davenport, A. P., Spedding, M., & Harmar, A. J. (2005) · Pharmacological Reviews · doi:10.1124/pr.57.2.5 · Cited by 592
Meier, P. J., & Stieger, B. (2002) · Annual Review of Physiology · doi:10.1146/annurev.physiol.64.082201.100300 · Cited by 586
Tomlinson, E., Fu, L., John, L., Hultgren, B., Huang, X., Renz, M., Stephan, J. P., Tsai, S. P., Powell-Braxton, L., French, D., et al. (2002) · Endocrinology · doi:10.1210/endo.143.5.8850 · Cited by 576
The Farnesoid X Receptor Modulates Adiposity and Peripheral Insulin Sensitivity in Mice
Cariou, B., van Harmelen, K., Duran-Sandoval, D., van Dijk, T. H., Grefhorst, A., Abdelkarim, M., Caron, S., Torpier, G., Fruchart, J.-C., Gonzalez, F. J., et al. (2006) · Journal of Biological Chemistry · doi:10.1074/jbc.m510258200 · Cited by 552
PGC-1 promotes insulin resistance in liver through PPAR-α-dependent induction of TRB-3
Koo, S.-H., Satoh, H., Herzig, S., Lee, C.-H., Hedrick, S., Kulkarni, R., Evans, R. M., Olefsky, J., & Montminy, M. (2004) · Nature Medicine · doi:10.1038/nm1044 · Cited by 550
A Natural Product That Lowers Cholesterol As an Antagonist Ligand for FXR
Urizar, N. L., Liverman, A. B., Dodds, D. T., Silva, F. V., Ordentlich, P., Yan, Y., Gonzalez, F. J., Heyman, R. A., Mangelsdorf, D. J., & Moore, D. D. (2002) · Science · doi:10.1126/science.1072891 · Cited by 549
Goetz, R., Beenken, A., Ibrahimi, O. A., Kalinina, J., Olsen, S. K., Eliseenkova, A. V., Xu, C., Neubert, T. A., Zhang, F., Linhardt, R. J., et al. (2007) · Molecular and Cellular Biology · doi:10.1128/mcb.02249-06 · Cited by 544
Identification of a Chemical Tool for the Orphan Nuclear Receptor FXR
Maloney, P. R., Parks, D. J., Haffner, C. D., Fivush, A. M., Chandra, G., Plunket, K. D., Creech, K. L., Moore, L. B., Wilson, J. G., Lewis, M. C., et al. (2000) · Journal of Medicinal Chemistry · doi:10.1021/jm0002127 · Cited by 527
Identification of Ligands for DAF-12 that Govern Dauer Formation and Reproduction in C. elegans
Motola, D. L., Cummins, C. L., Rottiers, V., Sharma, K. K., Li, T., Li, Y., Suino-Powell, K., Xu, H. E., Auchus, R. J., Antebi, A., et al. (2006) · Cell · doi:10.1016/j.cell.2006.01.037 · Cited by 485
SCHOENFIELD, L. J., LACHIN, J. M., BAUM, R. A., HABIG, R. L., HANSON, R. F., HERSH, T., HIGHTOWER, N. C., HOFMANN, A. F., LASSER, E. C., MARKS, J. W., et al. (1981) · Annals of Internal Medicine · doi:10.7326/0003-4819-95-3-257 · Cited by 485
Bile Acid Regulation of Gene Expression: Roles of Nuclear Hormone Receptors
Chiang, J. Y. L. (2002) · Endocrine Reviews · doi:10.1210/er.2000-0035 · Cited by 484
Redundant Pathways for Negative Feedback Regulation of Bile Acid Production
Wang, L., Lee, Y.-K., Bundman, D., Han, Y., Thevananther, S., Kim, C.-S., Chua, S. S., Wei, P., Heyman, R. A., Karin, M., et al. (2002) · Developmental Cell · doi:10.1016/s1534-5807(02)00187-9 · Cited by 476
A top‐down systems biology view of microbiome‐mammalian metabolic interactions in a mouse model
Martin, F. J., Dumas, M., Wang, Y., Legido‐Quigley, C., Yap, I. K. S., Tang, H., Zirah, S., Murphy, G. M., Cloarec, O., Lindon, J. C., et al. (2007) · Molecular Systems Biology · doi:10.1038/msb4100153 · Cited by 474
Human cholesterol 7α-hydroxylase (CYP7A1) deficiency has a hypercholesterolemic phenotype
Pullinger, C. R., Eng, C. S., Salen, G., Shefer, S., BATTA, A. K., Erickson, S. K., Verhagen, A., Rivera, C. R., Mulvihill, S. J., Malloy, M. J., et al. (2002) · Journal of Clinical Investigation · doi:10.1172/jci15387 · Cited by 468
Human cholesterol 7α-hydroxylase (CYP7A1) deficiency has a hypercholesterolemic phenotype
Pullinger, C. R., Eng, C., Salen, G., Shefer, S., Batta, A. K., Erickson, S. K., Verhagen, A., Rivera, C. R., Mulvihill, S. J., Malloy, M. J., et al. (2002) · Journal of Clinical Investigation · doi:10.1172/jci0215387 · Cited by 457
Liu, Y., Binz, J., Numerick, M. J., Dennis, S., Luo, G., Desai, B., MacKenzie, K. I., Mansfield, T. A., Kliewer, S. A., Goodwin, B., et al. (2003) · Journal of Clinical Investigation · doi:10.1172/jci18945 · Cited by 398
Grundy, S. M., AHRENS, E. H., & Salen, G. (1971) · PubMed · Cited by 396
Seol, W. (1995) · Molecular Endocrinology · doi:10.1210/me.9.1.72 · Cited by 393
A Chemical, Genetic, and Structural Analysis of the Nuclear Bile Acid Receptor FXR
Downes, M., Verdecia, M. A., Roecker, A. J., Hughes, R., Hogenesch, J. B., Kast-Woelbern, H. R., Bowman, M. E., Ferrer, J.-L., Anisfeld, A. M., Edwards, P. A., et al. (2003) · Molecular Cell · doi:10.1016/s1097-2765(03)00104-7 · Cited by 390
Zhang, Y., Castellani, L. W., Sinal, C. J., Gonzalez, F. J., & Edwards, P. A. (2004) · Genes & Development · doi:10.1101/gad.1138104 · Cited by 368
Yamagata, K., Daitoku, H., Shimamoto, Y., Matsuzaki, H., Hirota, K., Ishida, J., & Fukamizu, A. (2004) · Journal of Biological Chemistry · doi:10.1074/jbc.m314322200 · Cited by 364
Identification of a Bile Acid-responsive Element in the Human Ileal Bile Acid-binding Protein Gene
Grober, J., Zaghini, I., Fujii, H., Jones, S. A., Kliewer, S. A., Willson, T. M., Ono, T., & Besnard, P. (1999) · Journal of Biological Chemistry · doi:10.1074/jbc.274.42.29749 · Cited by 353
Kerr, T. A., Saeki, S., Schneider, M., Schaefer, K., Berdy, S., Redder, T., Shan, B., Russell, D. W., & Schwarz, M. (2002) · Developmental Cell · doi:10.1016/s1534-5807(02)00154-5 · Cited by 351
Anti-hyperglycemic activity of a TGR5 agonist isolated from Olea europaea
Sato, H., Genet, C., Strehle, A., Thomas, C., Lobstein, A., Wagner, A., Mioskowski, C., Auwerx, J., & Saladin, R. (2007) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2007.06.130 · Cited by 340
Self-citationKast, H. R., Nguyen, C. M., Sinal, C. J., Jones, S. A., Laffitte, B. A., Reue, K., Gonzalez, F. J., Willson, T. M., & Edwards, P. A. (2001) · Molecular Endocrinology · doi:10.1210/mend.15.10.0712 · Cited by 336
Zollner, G., Marschall, H.-U., Wagner, M., & Trauner, M. (2006) · Molecular Pharmaceutics · doi:10.1021/mp060010s · Cited by 335
Prevention of cholesterol gallstone disease by FXR agonists in a mouse model
Moschetta, A., Bookout, A. L., & Mangelsdorf, D. J. (2004) · Nature Medicine · doi:10.1038/nm1138 · Cited by 325
Gupta, S., Stravitz, R. T., Dent, P., & Hylemon, P. B. (2001) · Journal of Biological Chemistry · doi:10.1074/jbc.m010878200 · Cited by 322
The G-protein coupled bile salt receptor TGR5 is expressed in liver sinusoidal endothelial cells
Keitel, V., Reinehr, R., Gatsios, P., Rupprecht, C., Görg, B., Selbach, O., Häussinger, D., & Kubitz, R. (2007) · Hepatology · doi:10.1002/hep.21458 · Cited by 310
Structural Basis for Bile Acid Binding and Activation of the Nuclear Receptor FXR
Mi, L.-Z., Devarakonda, S., Harp, J. M., Han, Q., Pellicciari, R., Willson, T. M., Khorasanizadeh, S., & Rastinejad, F. (2003) · Molecular Cell · doi:10.1016/s1097-2765(03)00112-6 · Cited by 307
Self-citationGautam, D., Han, S.-J., Hamdan, F. F., Jeon, J., Li, B., Li, J. H., Cui, Y., Mears, D., Lu, H., Deng, C., et al. (2006) · Cell Metabolism · doi:10.1016/j.cmet.2006.04.009 · Cited by 299
Sato, H., Macchiarulo, A., Thomas, C., Gioiello, A., Une, M., Hofmann, A. F., Saladin, R., Schoonjans, K., Pellicciari, R., & Auwerx, J. (2008) · Journal of Medicinal Chemistry · doi:10.1021/jm7015864 · Cited by 298
Self-citationIdentification of a hormonal basis for gallbladder filling
Choi, M., Moschetta, A., Bookout, A. L., Peng, L., Umetani, M., Holmstrom, S. R., Suino-Powell, K., Xu, H. E., Richardson, J. A., Gerard, R. D., et al. (2006) · Nature Medicine · doi:10.1038/nm1501 · Cited by 294
Regulation of Carbohydrate Metabolism by the Farnesoid X Receptor
Stayrook, K. R., Bramlett, K. S., Savkur, R. S., Ficorilli, J., Cook, T., Christe, M. E., Michael, L. F., & Burris, T. P. (2005) · Endocrinology · doi:10.1210/en.2004-0965 · Cited by 288
Targeted disruption of G protein-coupled bile acid receptor 1 (Gpbar1/M-Bar) in mice
Maruyama, T., Tanaka, K., Suzuki, J., Miyoshi, H., Harada, N., Nakamura, T., Miyamoto, Y., Kanatani, A., & Tamai, Y. (2006) · Journal of Endocrinology · doi:10.1677/joe.1.06546 · Cited by 288
Zhang, Y., Kast-Woelbern, H. R., & Edwards, P. A. (2003) · Journal of Biological Chemistry · doi:10.1074/jbc.m209505200 · Cited by 286
Liver-specific Activities of FGF19 Require Klotho beta
Lin, B. C., Wang, M., Blackmore, C., & Desnoyers, L. R. (2007) · Journal of Biological Chemistry · doi:10.1074/jbc.m704244200 · Cited by 283
Targeted deletion of Gpbar1 protects mice from cholesterol gallstone formation
Vassileva, G., Golovko, A., Markowitz, L., Abbondanzo, S. J., Zeng, M., Yang, S., Hoos, L., Tetzloff, G., Levitan, D., Murgolo, N. J., et al. (2006) · Biochemical Journal · doi:10.1042/bj20060537 · Cited by 277
Disruption of Cholesterol 7α-Hydroxylase Gene in Mice
Schwarz, M., Lund, E. G., Setchell, K. D. R., Kayden, H. J., Zerwekh, J. E., Björkhem, I., Herz, J., & Russell, D. W. (1996) · Journal of Biological Chemistry · doi:10.1074/jbc.271.30.18024 · Cited by 270
Coordinate transcriptional regulation of bile acid homeostasis and drug metabolism
Eloranta, J. J., & Kullak-Ublick, G. A. (2005) · Archives of Biochemistry and Biophysics · doi:10.1016/j.abb.2004.09.019 · Cited by 260
Impaired negative feedback suppression of bile acid synthesis in mice lacking βKlotho
Ito, S., Fujimori, T., Furuya, A., Satoh, J., Nabeshima, Y., & Nabeshima, Y.-I. (2005) · Journal of Clinical Investigation · doi:10.1172/jci23076 · Cited by 248
Transcriptional Regulation of the Human Sterol 12α-Hydroxylase Gene (CYP8B1)
Zhang, M., & Chiang, J. Y. L. (2001) · Journal of Biological Chemistry · doi:10.1074/jbc.m105117200 · Cited by 247
Cui, J., Huang, L., Zhao, A., Lew, J.-L., Yu, J., Sahoo, S., Meinke, P. T., Royo, I., Peláez, F., & Wright, S. D. (2003) · Journal of Biological Chemistry · doi:10.1074/jbc.m209323200 · Cited by 246
Guggulipid for the Treatment of Hypercholesterolemia: A Randomized Controlled Trial
Szapary, P. O., Wolfe, M. L., Bloedon, L. T., Cucchiara, A. J., DerMarderosian, A. H., Cirigliano, M. D., & Rader, D. J. (2003) · JAMA · doi:10.1001/jama.290.6.765 · Cited by 246
Gerisch, B., Rottiers, V., Li, D., Motola, D. L., Cummins, C. L., Lehrach, H., Mangelsdorf, D. J., & Antebi, A. (2007) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0700847104 · Cited by 242
Duran-Sandoval, D., Cariou, B., Percevault, F., Hennuyer, N., Grefhorst, A., van Dijk, T. H., Gonzalez, F. J., Fruchart, J.-C., Kuipers, F., & Staels, B. (2005) · Journal of Biological Chemistry · doi:10.1074/jbc.m501931200 · Cited by 239
Disruption of Cholesterol 7α-Hydroxylase Gene in Mice
Ishibashi, S., Schwarz, M., Frykman, P. K., Herz, J., & Russell, D. W. (1996) · Journal of Biological Chemistry · doi:10.1074/jbc.271.30.18017 · Cited by 237
Farnesoid X Receptor Modulates Renal Lipid Metabolism, Fibrosis, and Diabetic Nephropathy
Jiang, T., Wang, X. X., Scherzer, P., Wilson, P., Tallman, J., Takahashi, H., Li, J., Iwahashi, M., Sutherland, E., Arend, L., et al. (2007) · Diabetes · doi:10.2337/db06-1642 · Cited by 236
Cholestanol Deposition in Cerebrotendinous Xanthomatosis: A Possible Mechanism
SALEN, G. (1971) · Annals of Internal Medicine · doi:10.7326/0003-4819-75-6-843 · Cited by 230
Cholic acid mediates negative feedback regulation of bile acid synthesis in mice
Li-Hawkins, J., Gåfvels, M., Olin, M., Lund, E. G., Andersson, U., Schuster, G., Björkhem, I., Russell, D. W., & Eggertsen, G. (2002) · Journal of Clinical Investigation · doi:10.1172/jci0216309 · Cited by 227
Rao, A., Haywood, J., Craddock, A. L., Belinsky, M. G., Kruh, G. D., & Dawson, P. A. (2008) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0712328105 · Cited by 225
Landrier, J.-F., Eloranta, J. J., Vavricka, S. R., & Kullak-Ublick, G. A. (2006) · American Journal of Physiology-Gastrointestinal and Liver Physiology · doi:10.1152/ajpgi.00430.2005 · Cited by 213
Generation of multiple farnesoid-X-receptor isoforms through the use of alternative promoters
Huber, R. M., Murphy, K., Miao, B., Link, J. R., Cunningham, M. R., Rupar, M. J., Gunyuzlu, P. L., Haws, T. F., Kassam, A., Powell, F., et al. (2002) · Gene · doi:10.1016/s0378-1119(02)00557-7 · Cited by 210
De Fabiani, E., Mitro, N., Gilardi, F., Caruso, D., Galli, G., & Crestani, M. (2003) · Journal of Biological Chemistry · doi:10.1074/jbc.m305079200 · Cited by 210
Wang, D. Q.-H., Tazuma, S., Cohen, D. E., & Carey, M. C. (2003) · American Journal of Physiology-Gastrointestinal and Liver Physiology · doi:10.1152/ajpgi.00156.2003 · Cited by 210
FXR signaling in metabolic disease
Zhang, Y., & Edwards, P. A. (2008) · FEBS Letters · doi:10.1016/j.febslet.2007.11.015 · Cited by 209
Brendel, C., Schoonjans, K., Botrugno, O. A., Treuter, E., & Auwerx, J. (2002) · Molecular Endocrinology · doi:10.1210/me.2001-0194 · Cited by 201
Self-citationFarnesoid X Receptor Regulates Bile Acid-Amino Acid Conjugation
Pircher, P. C., Kitto, J. L., Petrowski, M. L., Tangirala, R. K., Bischoff, E. D., Schulman, I. G., & Westin, S. K. (2003) · Journal of Biological Chemistry · doi:10.1074/jbc.m302128200 · Cited by 198
Differential Regulation of Rat and Human CYP7A1 by the Nuclear Oxysterol Receptor Liver X Receptor-α
Goodwin, B., Watson, M. A., Kim, H., Miao, J., Kemper, J. K., & Kliewer, S. A. (2003) · Molecular Endocrinology · doi:10.1210/me.2002-0246 · Cited by 198
The Hypolipidemic Natural Product Guggulsterone Acts as an Antagonist of the Bile Acid Receptor
Wu, J. (2002) · Molecular Endocrinology · doi:10.1210/me.16.7.1590 · Cited by 196
Targeting farnesoid X receptor for liver and metabolic disorders
Fiorucci, S., Rizzo, G., Donini, A., Distrutti, E., & Santucci, L. (2007) · Trends in Molecular Medicine · doi:10.1016/j.molmed.2007.06.001 · Cited by 196
Garg, A., & Grundy, S. M. (1994) · Annals of Internal Medicine · doi:10.7326/0003-4819-121-6-199409150-00004 · Cited by 187
De Fabiani, E., Mitro, N., Anzulovich, A. C., Pinelli, A., Galli, G., & Crestani, M. (2001) · Journal of Biological Chemistry · doi:10.1074/jbc.m103270200 · Cited by 184
Angelin, B., Einarsson, K., Hellström, K., & Leijd, B. (1978) · Journal of Lipid Research · doi:10.1016/s0022-2275(20)40685-6 · Cited by 179
FXR regulates organic solute transporters α and β in the adrenal gland, kidney, and intestine
Lee, H., Zhang, Y., Lee, F. Y., Nelson, S. F., Gonzalez, F. J., & Edwards, P. A. (2006) · Journal of Lipid Research · doi:10.1194/jlr.m500417-jlr200 · Cited by 178
The Metabolism of Cholestanol, Cholesterol, and Bile Acids in Cerebrotendinous Xanthomatosis
Salen, G., & Grundy, S. M. (1973) · Journal of Clinical Investigation · doi:10.1172/jci107478 · Cited by 176
Identification of Farnesoid X Receptor β as a Novel Mammalian Nuclear Receptor Sensing Lanosterol
Otte, K., Kranz, H., Kober, I., Thompson, P., Hoefer, M., Haubold, B., Remmel, B., Voss, H., Kaiser, C., Albers, M., et al. (2003) · Molecular and Cellular Biology · doi:10.1128/mcb.23.3.864-872.2003 · Cited by 176
Prevention and Treatment of Obesity, Insulin Resistance, and Diabetes by Bile Acid–Binding Resin
Kobayashi, M., Ikegami, H., Fujisawa, T., Nojima, K., Kawabata, Y., Noso, S., Babaya, N., Itoi-Babaya, M., Yamaji, K., Hiromine, Y., et al. (2007) · Diabetes · doi:10.2337/db06-0353 · Cited by 167
Nishigori, H., Tomura, H., Tonooka, N., Kanamori, M., Yamada, S., Sho, K., Inoue, I., Kikuchi, N., Onigata, K., Kojima, I., et al. (2001) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.98.2.575 · Cited by 165
Qiao, L., Han, S. I., Fang, Y., Park, J. S., Gupta, S., Gilfor, D., Amorino, G. P., Valerie, K. C., Sealy, L. J., Engelhardt, J. F., et al. (2003) · Molecular and Cellular Biology · doi:10.1128/mcb.23.9.3052-3066.2003 · Cited by 162
Transcriptional corepression by SHP: molecular mechanisms and physiological consequences
Båvner, A., Sanyal, S., Gustafsson, J.-Å., & Treuter, E. (2005) · Trends in Endocrinology and Metabolism · doi:10.1016/j.tem.2005.10.005 · Cited by 159
Wang, L., Liu, J., Saha, P. K., Huang, J., Chan, L., Spiegelman, B. M., & Moore, D. D. (2005) · Cell Metabolism · doi:10.1016/j.cmet.2005.08.010 · Cited by 155
Lee, Y.-K., Schmidt, D. R., Cummins, C. L., Choi, M., Peng, L., Zhang, Y., Goodwin, B. J., Hammer, R. E., Mangelsdorf, D. J., & Kliewer, S. A. (2008) · Molecular Endocrinology · doi:10.1210/me.2007-0565 · Cited by 154
Mataki, C., Magnier, B. C., Houten, S. M., Annicotte, J., Argmann, C., Thomas, C., Overmars, H., Kulik, W., METZGER, D., Auwerx, J. H., et al. (2007) · Molecular and Cellular Biology · doi:10.1128/mcb.00852-07 · Cited by 148
Self-citationCo-receptor Requirements for Fibroblast Growth Factor-19 Signaling
Wu, X., Ge, H., Gupte, J., Weiszmann, J., Shimamoto, G., Stevens, J., Hawkins, N., Lemon, B., Shen, W., Xu, J., et al. (2007) · Journal of Biological Chemistry · doi:10.1074/jbc.c700130200 · Cited by 140
Fang, Y., Han, S. I., Mitchell, C., Gupta, S., Studer, E. J., Grant, S., Hylemon, P. B., & Dent, P. (2004) · Hepatology · doi:10.1002/hep.1840400427 · Cited by 140
Regulation of bile acid biosynthesis by hepatocyte nuclear factor 4α
Inoue, Y., Yu, A., Yim, S. H., Ma, X., Krausz, K. W., Inoue, J., Xiang, C. C., Brownstein, M., Eggertsen, G., Björkhem, I., et al. (2005) · Journal of Lipid Research · doi:10.1194/jlr.m500430-jlr200 · Cited by 137
Farnesoid X Receptor: From Structure to Potential Clinical Applications
Pellicciari, R., Costantino, G., & Fiorucci, S. (2005) · Journal of Medicinal Chemistry · doi:10.1021/jm0582221 · Cited by 129
Self-citationYasuda, H., Hirata, S., Inoue, K., Mashima, H., Ohnishi, H., & Yoshiba, M. (2006) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2006.12.168 · Cited by 126
Activation and role of mitogen-activated protein kinases in deoxycholic acid-induced apoptosis
Qiao, D., Stratagouleas, E. D., & Martinez, J. D. (2001) · Carcinogenesis · doi:10.1093/carcin/22.1.35 · Cited by 126
Dent, P., Fang, Y., Gupta, S., Studer, E. J., Mitchell, C., Spiegel, S., & Hylemon, P. B. (2005) · Hepatology · doi:10.1002/hep.20942 · Cited by 125
Identification of Gene-selective Modulators of the Bile Acid Receptor FXR
Dussault, I., Beard, R., Lin, M., Hollister, K., Chen, J., Xiao, J. H., Chandraratna, R., & FORMAN, B. M. (2003) · Journal of Biological Chemistry · doi:10.1074/jbc.m209863200 · Cited by 106
Miller, N. E., & Nestel, P. J. (1974) · The Lancet · doi:10.1016/s0140-6736(74)91134-9 · Cited by 106
Pellicciari, R., Sato, H., Gioiello, A., Costantino, G., Macchiarulo, A., Sadeghpour, B. M., Giorgi, G., Schoonjans, K., & Auwerx, J. H. (2007) · Journal of Medicinal Chemistry · doi:10.1021/jm070633p · Cited by 105
Self-citationGriffiths, E. J., Stern, M. D., & Silverman, H. S. (1997) · American Journal of Physiology-Cell Physiology · doi:10.1152/ajpcell.1997.273.1.c37 · Cited by 97
Activation of the farnesoid X receptor improves lipid metabolism in combined hyperlipidemic hamsters
Bilz, S., Samuel, V. T., Morino, K., Savage, D. B., Choi, C. S., & Shulman, G. I. (2005) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.00355.2005 · Cited by 93
Nuclear bile acid receptor FXR as pharmacological target: Are we there yet?
Modica, S., & Moschetta, A. (2006) · FEBS Letters · doi:10.1016/j.febslet.2006.07.082 · Cited by 89
Transient impairment of the adaptive response to fasting in FXR‐deficient mice
Cariou, B., van Harmelen, K., Durán-Sandoval, D., van Dijk, T. H., Grefhorst, A., Bouchaert, E., Fruchart, J., Gonzalez, F. J., Kuipers, F., & Staels, B. (2005) · FEBS Letters · doi:10.1016/j.febslet.2005.06.033 · Cited by 87
Identification of a bile acid response element in the cholesterol 7 alpha-hydroxylase gene CYP7A
Stroup, D., Crestani, M., & Chiang, J. Y. L. (1997) · American Journal of Physiology-Gastrointestinal and Liver Physiology · doi:10.1152/ajpgi.1997.273.2.g508 · Cited by 84
The nuclear bile acid receptor FXR is activated by PGC-1α in a ligand-dependent manner
Kanaya, E. N., Shiraki, T., & Jingami, H. (2004) · Biochemical Journal · doi:10.1042/bj20040432 · Cited by 76
Ikemoto, S., Takahashi, M. M., Tsunoda, N., Maruyama, K., Itakura, H., Kawanaka, K., Tabata, I., Higuchi, M., Tange, T., Yamamoto, T. T., et al. (1997) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.1997.273.1.e37 · Cited by 76
Yang, J. I., Yoon, J., Myung, S. J., Gwak, G., Kim, W. K., Chung, G. E., Lee, S. H., Lee, S., Kim, C. Y., & Lee, H.-S. (2007) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2007.07.001 · Cited by 74
Pandak, W. M., Bohdan, P. M., Franklund, C. V., Mallonee, D. H., Eggertsen, G., Björkhem, I., Gil, G., Vlahčevič, Z. R., & Hylemon, P. B. (2001) · Gastroenterology · doi:10.1053/gast.2001.24833 · Cited by 70
Yamakawa, T., Takano, T., Utsunomiya, H., Kadonosono, K., & OKAMURA, A. (2007) · Endocrine Journal · doi:10.1507/endocrj.k05-098 · Cited by 70
The Metabolism of Chenodeoxycholic Acid to β‐Muricholic Acid in Rat Liver
Botham, K. M., & Boyd, G. S. (1983) · European Journal of Biochemistry · doi:10.1111/j.1432-1033.1983.tb07550.x · Cited by 69
West, K. L., Zern, T. L., Butteiger, D. N., Keller, B. T., & Fernández, M. L. (2003) · Atherosclerosis · doi:10.1016/j.atherosclerosis.2003.08.019 · Cited by 68
Houten, S. M., Volle, D. H., Cummins, C. L., Mangelsdorf, D. J., & Auwerx, J. H. (2007) · Molecular Endocrinology · doi:10.1210/me.2007-0113 · Cited by 68
Self-citationHan, S. I., Studer, E. J., Gupta, S., Fang, Y., Qiao, L., Li, W., Grant, S., Hylemon, P. B., & Dent, P. (2004) · Hepatology · doi:10.1002/hep.20043 · Cited by 68
Everson, G. T. (1987) · Journal of Lipid Research · doi:10.1016/s0022-2275(20)38702-2 · Cited by 66
Stamp, D. (2002) · Medical Hypotheses · doi:10.1016/s0306-9877(02)00125-1 · Cited by 63
Hung, C.-C. C., Farooqi, I. S., Ong, K. K., Luan, J., Keogh, J. M., Pembrey, M. E., Yeo, G. S. H., Dunger, D. B., Wareham, N. J., & O’Rahilly, S. (2003) · Diabetes · doi:10.2337/diabetes.52.5.1288 · Cited by 63
Chen, X., Yang, D., Shen, W., Dong, H., Wang, J. M., Oppenheim, J. J., & Howard, O. M. Z. (2000) · Inflammation Research · doi:10.1007/s000110050656 · Cited by 60
Li, H., Xu, G., Shang, Q., Pan, L., Shefer, S., BATTA, A. K., Bollineni, J. S., Tint, G. S., Keller, B. T., & Salen, G. (2004) · Metabolism · doi:10.1016/j.metabol.2004.01.017 · Cited by 58
Rat liver bile acid CoA:amino acid N-acyltransferase
He, D., Barnes, S. H., & Falany, C. N. (2003) · Journal of Lipid Research · doi:10.1194/jlr.m300128-jlr200 · Cited by 56
Modulation of Longevity by Environmental Sensing
Libert, S., & Pletcher, S. D. (2007) · Cell · doi:10.1016/j.cell.2007.12.002 · Cited by 56
Leiß, O., & von Bergmann, K. (1982) · Scandinavian Journal of Gastroenterology · doi:10.3109/00365528209181063 · Cited by 53
Mitchell, S. M. S., Weedon, M. N., Owen, K. R., Shields, B. M., Wilkins-Wall, B., Walker, M., McCarthy, M. I., Frayling, T. M., & Hattersley, A. T. (2003) · Diabetes · doi:10.2337/diabetes.52.5.1276 · Cited by 51
Houten, S. M., & Auwerx, J. H. (2004) · Annals of Medicine · doi:10.1080/07853890410018790 · Cited by 50
Self-citationFang, Y., Studer, E. J., Mitchell, C., Grant, S., Pandak, W. M., Hylemon, P. B., & Dent, P. (2007) · Molecular Pharmacology · doi:10.1124/mol.106.032060 · Cited by 50
Changes in plasma triglyceride metabolism during withdrawal of bile
Nestel, P. J., & Grundy, S. M. (1976) · Metabolism · doi:10.1016/s0026-0495(76)80009-1 · Cited by 44
Cai, S., Xiong, L.-S., Wray, C. G., Ballatori, N., & Boyer, J. L. (2007) · American Journal of Physiology-Regulatory, Integrative and Comparative Physiology · doi:10.1152/ajpregu.00781.2006 · Cited by 44
Raufman, J., Zimniak, P., & Bartoszko‐Malik, A. (1998) · American Journal of Physiology-Gastrointestinal and Liver Physiology · doi:10.1152/ajpgi.1998.274.6.g997 · Cited by 40
Pharmacophore model for bile acids recognition by the FPR receptor
Ferrari, C., Macchiarulo, A., Costantino, G., & Pellicciari, R. (2006) · Journal of Computer-Aided Molecular Design · doi:10.1007/s10822-006-9055-1 · Cited by 37
Self-citationCircadian distribution of bile acids in the enterohepatic circulatory system in rats
Ho, K. (1976) · American Journal of Physiology-Legacy Content · doi:10.1152/ajplegacy.1976.230.5.1331 · Cited by 36
Human CYP7A1 deficiency: progress and enigmas
Beigneux, A. P., Hofmann, A. F., & Young, S. G. (2002) · Journal of Clinical Investigation · doi:10.1172/jci0216076 · Cited by 36
Podevin, P., Calmus, Y., Bonnefis, M. T., Veyrunes, C., Chéreau, C., & Poupon, R. Y. (1995) · Gastroenterology · doi:10.1016/0016-5085(95)90219-8 · Cited by 35
Inaba, T., Ishibashi, S., Harada, K., Ohsuga, J.-I., Ohashi, K., Yagyu, H., Yazaki, Y., Higashiyama, S., Kawata, S., Matsuzawa, Y., et al. (1996) · Journal of Biological Chemistry · doi:10.1074/jbc.271.40.24413 · Cited by 35
Human CYP7A1 deficiency: progress and enigmas
Beigneux, A. P., Hofmann, A. F., & Young, S. G. (2002) · Journal of Clinical Investigation · doi:10.1172/jci16076 · Cited by 34
Meyer, U., Costantino, G., Macchiarulo, A., & Pellicciari, R. (2005) · Journal of Medicinal Chemistry · doi:10.1021/jm0505056 · Cited by 34
Self-citationMolecular cloning and expression of rat liver bile acid CoA ligase
Falany, C. N., Xie, X., Wheeler, J. B., Wang, J., Smith, M., He, D., & Barnes, S. (2002) · Journal of Lipid Research · doi:10.1194/jlr.m200260-jlr200 · Cited by 32
Bile Acid Coenzyme A: Amino Acid N‐Acyltransferase in the Amino Acid Conjugation of Bile Acids
Shonsey, E. M., Sfakianos, M. K., Johnson, M. S., He, D., Falany, C. N., Falany, J. L., Merkler, D. J., & Barnes, S. (2005) · Methods in enzymology on CD-ROM/Methods in enzymology · doi:10.1016/s0076-6879(05)00022-4 · Cited by 30
Improving metabolism by increasing energy expenditure
Auwerx, J. H. (2006) · Nature Medicine · doi:10.1038/nm0106-44 · Cited by 28
Self-citationEngelking, L. R., Dasher, C. A., & Hirschowitz, B. I. (1980) · American Journal of Clinical Pathology · doi:10.1093/ajcp/73.2.196 · Cited by 27
Sakamoto, S. X., Kusuhara, H., Miyata, K., Shimaoka, H., Kanazu, T., Matsuo, Y., Nomura, K., Okamura, N., Hara, S., Horie, K., et al. (2007) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.106.116426 · Cited by 24
Bile acid-mediated induction of cyclooxygenase-2 and Mcl-1 in hepatic stellate cells
Kim, K. M., Yoon, J., Gwak, G., Kim, W. K., Lee, S. H., Jang, J. J., & Lee, H. (2006) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2006.02.072 · Cited by 12
Research works printed but not linked: 1
- Harnish, D. C. et al. A synthetic farnesoid X receptor (FXR) agonist protects against diet-induced dyslipidemia. J. Clin. Lipidol. 1, 362 (2007).
Cited by
Cryan, J. F., O'Riordan, K. J., Cowan, C. S. M., Sandhu, K. V., Bastiaanssen, T. F. S., Boehme, M., Codagnone, M. G., Cussotto, S., Fulling, C., Golubeva, A. V., et al. (2019) · Physiological Reviews · doi:10.1152/physrev.00018.2018 · Cited by 5,286
Intestinal Crosstalk between Bile Acids and Microbiota and Its Impact on Host Metabolism
Wahlström, A., Sayin, S. I., Marschall, H.-U., & Bäckhed, F. (2016) · Cell Metabolism · doi:10.1016/j.cmet.2016.05.005 · Cited by 2,851
“The classical (or neutral) pathway accounts for at least 75% of bile acid production under normal conditions and is initiated by 7a-hydroxylation of cholesterol catalyzed by cholesterol 7a-hydroxylase (CYP7A1) (Thomas et al., 2008).”
Sayin, S. I., Wahlström, A., Felin, J., Jäntti, S., Marschall, H.-U., Bamberg, K., Angelin, B., Hyötyläinen, T., Orešič, M., & Bäckhed, F. (2013) · Cell Metabolism · doi:10.1016/j.cmet.2013.01.003 · Cited by 2,331
“…regulate their own biosynthesis but also Cell M modulate key metabolic pathways involved in lipoprotein, glucose, drug, and energy metabolism by activation of nuclear receptors such as farnesoid X receptor (FXR) and the G protein-coupled receptor TGR5 (Hylemon et al., 2009; Thomas et al., 2008).”
Diet–microbiota interactions as moderators of human metabolism
Sonnenburg, J. L., & Bäckhed, F. (2016) · Nature · doi:10.1038/nature18846 · Cited by 2,257
Bile acid-microbiota crosstalk in gastrointestinal inflammation and carcinogenesis
Jia, W., Xie, G., & Jia, W. (2018) · Nature Reviews Gastroenterology & Hepatology · doi:10.1038/nrgastro.2017.119 · Cited by 1,924
Metadata
- Authors
- Thomas, C., Pellicciari, R., Pruzanski, M., Auwerx, J., & Schoonjans, K.
- Affiliations
- Institut de génétique et de biologie moléculaire et cellulaire (FR)
- University of Perugia (IT)
- Intercept Pharmaceuticals (United States) (US)
- Corresponding author
- Auwerx, Johan
- Schoonjans, Kristina
- Venue
- Nature Reviews Drug Discovery
- Published
- 2008-08
- Volume
- 7
- Issue
- 8
- Pages
- 678-693
- ISSN
- 1474-1776 (ISSN-L)
- 1474-1784
- OpenAlex
- W2078810890
- Cited by
- 1,422
- References
- 169
- Citations by year
- 2026: 81 · 2025: 92 · 2024: 106 · 2023: 107 · 2022: 113 · 2021: 90 · 2020: 83 · 2019: 82 · 2018: 78 · 2017: 81 · 2016: 75 · 2015: 75 · 2014: 71 · 2013: 77 · 2012: 47
- FWCI
- 5.13
- Type
- journal article
- Language
- en
- Open access
- green
- infoscience.epfl.ch
- Licence
- www.springer.com/tdm (tdm)
- www.springer.com/tdm (vor)
- Locations
- Nature Reviews Drug Discovery (publishedVersion)
- PubMed (publishedVersion)
- HAL (submittedVersion)
- Infoscience (Ecole Polytechnique Fédérale de Lausanne) (submittedVersion)
- Infoscience (Ecole Polytechnique Fédérale de Lausanne) (submittedVersion, cc-by-nc-nd)
- Funders
- European Commission
- Institut National de la Santé et de la Recherche Médicale
- Fondation pour la Recherche Médicale
- Ligue Contre le Cancer
- Centre National de la Recherche Scientifique
- Société Française de Nutrition
- Topics
- Health Sciences › Medicine › Oncology › Drug Transport and Resistance Mechanisms
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Biochemistry › Cholesterol and Lipid Metabolism
- Health Sciences › Medicine › Pharmacology (medical) › Berberine and alkaloids research
- Keywords
- bile acids, bile acid signaling, metabolic disorders, obesity, type 2 diabetes, hypertriglyceridemia, atherosclerosis, nonalcoholic steatohepatitis, therapeutic target, drug development
- MeSH terms
- Animals, Bile Acids and Salts, Humans, Metabolic Diseases, Signal Transduction, Drug Delivery Systems
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.